$AVM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMAG PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMAG PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AMAG PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 17 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Sell | S | 70.71 | 10,000 | 707,126 | 210,252 | 220.3 K to 210.3 K (-4.54 %) |
Apr 10 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Sell | S | 64.75 | 10,000 | 647,509 | 220,252 | 230.3 K to 220.3 K (-4.34 %) |
Apr 10 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Sell | S | 64.75 | 10,000 | 647,509 | 220,252 | 230.3 K to 220.3 K (-4.34 %) |
Apr 06 2007 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO & Chief Busine ... | Option Exercise | A | 0.00 | 3,000 | 0 | 3,000 | |
Apr 06 2007 | AVM | AMAG PHARMACEUTICA ... | Arkowitz David | CFO & Chief Busine ... | Option Exercise | M | 65.22 | 50,000 | 3,261,000 | 50,000 | |
Apr 03 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.33 | 10,000 | 603,320 | 230,242 | 240.2 K to 230.2 K (-4.16 %) |
Apr 03 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.33 | 10,000 | 603,320 | 230,252 | 240.3 K to 230.3 K (-4.16 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.25 | 34 | 2,049 | 105,108 | 105.1 K to 105.1 K (-0.03 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.13 | 250 | 15,033 | 105,142 | 105.4 K to 105.1 K (-0.24 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.12 | 50 | 3,006 | 105,392 | 105.4 K to 105.4 K (-0.05 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.10 | 50 | 3,005 | 105,442 | 105.5 K to 105.4 K (-0.05 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.09 | 200 | 12,018 | 105,492 | 105.7 K to 105.5 K (-0.19 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.07 | 200 | 12,014 | 105,692 | 105.9 K to 105.7 K (-0.19 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.05 | 366 | 21,978 | 105,892 | 106.3 K to 105.9 K (-0.34 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.04 | 500 | 30,020 | 106,258 | 106.8 K to 106.3 K (-0.47 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.03 | 300 | 18,009 | 106,758 | 107.1 K to 106.8 K (-0.28 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.02 | 449 | 26,949 | 107,058 | 107.5 K to 107.1 K (-0.42 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.01 | 551 | 33,066 | 107,507 | 108.1 K to 107.5 K (-0.51 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.00 | 2,050 | 123,000 | 108,058 | 110.1 K to 108.1 K (-1.86 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.25 | 34 | 2,049 | 67,965 | 68 K to 68 K (-0.05 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.13 | 250 | 15,033 | 67,799 | 68 K to 67.8 K (-0.37 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.12 | 50 | 3,006 | 68,249 | 68.3 K to 68.2 K (-0.07 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.10 | 50 | 3,005 | 68,299 | 68.3 K to 68.3 K (-0.07 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.09 | 200 | 12,018 | 68,349 | 68.5 K to 68.3 K (-0.29 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.07 | 200 | 12,014 | 68,549 | 68.7 K to 68.5 K (-0.29 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.05 | 366 | 21,978 | 68,749 | 69.1 K to 68.7 K (-0.53 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.04 | 500 | 30,020 | 69,115 | 69.6 K to 69.1 K (-0.72 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.03 | 300 | 18,009 | 69,615 | 69.9 K to 69.6 K (-0.43 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.02 | 448 | 26,889 | 69,915 | 70.4 K to 69.9 K (-0.64 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.01 | 552 | 33,126 | 70,363 | 70.9 K to 70.4 K (-0.78 %) |
Mar 28 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Sell | S | 60.00 | 2,050 | 123,000 | 70,915 | 73 K to 70.9 K (-2.81 %) |
Mar 19 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tr ... | Sell | S | 56.24 | 10,000 | 562,414 | 110,108 | 120.1 K to 110.1 K (-8.33 %) |
Mar 19 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tr ... | Sell | S | 56.24 | 10,000 | 562,405 | 120,108 | 130.1 K to 120.1 K (-7.69 %) |
Mar 19 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tr ... | Sell | S | 56.24 | 10,000 | 562,414 | 72,965 | 83 K to 73 K (-12.05 %) |
Mar 19 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tr ... | Sell | S | 56.24 | 10,000 | 562,405 | 82,965 | 93 K to 83 K (-10.76 %) |
Mar 19 2007 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tr ... | Gift | G | 0.00 | 1,200 | 0 | 92,965 | 94.2 K to 93 K (-1.27 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | M | 8.98 | 8,000 | 71,840 | 0 | |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | M | 12.28 | 12,000 | 147,360 | 3,000 | |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Sell | S | 56.42 | 1,505 | 84,912 | 0 | 1.5 K to 0 (-100.00 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Sell | S | 56.51 | 3,495 | 197,502 | 1,505 | 5 K to 1.5 K (-69.90 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Sell | S | 56.80 | 7,000 | 397,600 | 5,000 | 12 K to 5 K (-58.33 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Sell | S | 57.10 | 8,000 | 456,800 | 12,000 | 20 K to 12 K (-40.00 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Buy | M | 8.98 | 8,000 | 71,840 | 20,000 | 12 K to 20 K (+66.67 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Buy | M | 12.28 | 12,000 | 147,360 | 12,000 | 0 to 12 K |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Option Exercise | M | 7.73 | 12,000 | 92,760 | 0 | |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Sell | S | 56.00 | 2,859 | 160,104 | 0 | 2.9 K to 0 (-100.00 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Sell | S | 54.79 | 2,500 | 136,975 | 2,859 | 5.4 K to 2.9 K (-46.65 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Sell | S | 54.50 | 2,500 | 136,250 | 5,359 | 7.9 K to 5.4 K (-31.81 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Sell | S | 54.58 | 4,141 | 226,016 | 7,859 | 12 K to 7.9 K (-34.51 %) |
Mar 09 2007 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel-VP Lega ... | Buy | M | 7.73 | 12,000 | 92,760 | 12,000 | 0 to 12 K |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Option Exercise | M | 9.11 | 1,250 | 11,388 | 0 | |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Option Exercise | M | 16.80 | 1,000 | 16,800 | 0 | |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Option Exercise | M | 14.70 | 2,000 | 29,400 | 0 | |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Buy | M | 9.11 | 1,250 | 11,388 | 4,250 | 3 K to 4.3 K (+41.67 %) |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Buy | M | 16.80 | 1,000 | 16,800 | 3,000 | 2 K to 3 K (+50.00 %) |
Feb 06 2007 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP - Finance & CFO | Buy | M | 14.70 | 2,000 | 29,400 | 2,000 | 0 to 2 K |
Dec 05 2006 | AVM | AMAG PHARMACEUTICA ... | Healey Timothy G | SVP-Commercial Oper ... | Option Exercise | A | 59.10 | 50,000 | 2,955,000 | 50,000 | |
Dec 05 2006 | AVM | AMAG PHARMACEUTICA ... | SCOON DAVEY | Director | Option Exercise | A | 59.10 | 6,128 | 362,165 | 6,128 | |
Nov 28 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 41.16 | 2,639 | 108,621 | 1,195 | |
Nov 28 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Payment of Exercise | F | 54.33 | 2,000 | 108,660 | 67,778 | 69.8 K to 67.8 K (-2.87 %) |
Nov 28 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 41.16 | 2,639 | 108,621 | 69,778 | 67.1 K to 69.8 K (+3.93 %) |
Nov 22 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Option Exercise | M | 5.65 | 6,250 | 35,338 | 0 | |
Nov 22 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Payment of Exercise | F | 59.40 | 595 | 35,343 | 94,165 | 94.8 K to 94.2 K (-0.63 %) |
Nov 22 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec. Chairman & T ... | Buy | M | 5.65 | 6,250 | 35,338 | 94,760 | 88.5 K to 94.8 K (+7.06 %) |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | ZWANZIGER RON | Director | Option Exercise | A | 41.16 | 8,801 | 362,249 | 8,801 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | STEINMAN THEODORE I | Director | Option Exercise | A | 41.16 | 3,834 | 157,807 | 3,834 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | SKALETSKY MARK B | Director | Option Exercise | A | 41.16 | 3,834 | 157,807 | 3,834 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Option Exercise | A | 41.16 | 3,834 | 157,807 | 3,834 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | Pereira Brian JG | President and CEO | Option Exercise | A | 41.16 | 50,000 | 2,058,000 | 50,000 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | NARACHI MICHAEL | Director | Option Exercise | A | 41.16 | 8,801 | 362,249 | 8,801 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | Exec Chairman & Tre ... | Option Exercise | A | 41.16 | 50,000 | 2,058,000 | 50,000 | |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | LOBERG MICHAEL D | Director | Option Exercise | A | 41.16 | 3,834 | 157,807 | 3,834 | |
Oct 04 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 19.98 | 2,000 | 39,960 | 0 | |
Oct 04 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Payment of Exercise | F | 34.37 | 1,163 | 39,972 | 67,139 | 68.3 K to 67.1 K (-1.70 %) |
Oct 04 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 19.98 | 2,000 | 39,960 | 68,302 | 66.3 K to 68.3 K (+3.02 %) |
Nov 09 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | A | 41.16 | 3,834 | 157,807 | 3,834 | |
Sep 15 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Sell | S | 33.82 | 1,200 | 40,584 | 0 | 1.2 K to 0 (-100.00 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 33.84 | 6,750 | 228,388 | 101,087 | 107.8 K to 101.1 K (-6.26 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 33.84 | 6,750 | 228,388 | 59,589 | 66.3 K to 59.6 K (-10.18 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 34.22 | 12,950 | 443,105 | 107,837 | 120.8 K to 107.8 K (-10.72 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 34.22 | 12,950 | 443,105 | 66,339 | 79.3 K to 66.3 K (-16.33 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 34.42 | 5,300 | 182,443 | 120,787 | 126.1 K to 120.8 K (-4.20 %) |
Sep 13 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 34.42 | 5,300 | 182,443 | 79,289 | 84.6 K to 79.3 K (-6.27 %) |
Sep 07 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 36.19 | 4,857 | 175,786 | 126,087 | 130.9 K to 126.1 K (-3.71 %) |
Sep 07 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 36.19 | 4,857 | 175,786 | 84,589 | 89.4 K to 84.6 K (-5.43 %) |
Sep 07 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 36.27 | 20,143 | 730,647 | 130,944 | 151.1 K to 130.9 K (-13.33 %) |
Sep 07 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 36.27 | 20,143 | 730,647 | 89,446 | 109.6 K to 89.4 K (-18.38 %) |
Aug 30 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 35.28 | 5,527 | 194,989 | 269,473 | 275 K to 269.5 K (-2.01 %) |
Aug 30 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 35.28 | 5,527 | 194,989 | 269,473 | 275 K to 269.5 K (-2.01 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.67 | 8,600 | 272,370 | 275,000 | 283.6 K to 275 K (-3.03 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.67 | 8,600 | 272,370 | 275,000 | 283.6 K to 275 K (-3.03 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.77 | 7,800 | 247,793 | 283,600 | 291.4 K to 283.6 K (-2.68 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.77 | 7,800 | 247,793 | 283,600 | 291.4 K to 283.6 K (-2.68 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.40 | 8,600 | 270,054 | 291,400 | 300 K to 291.4 K (-2.87 %) |
Aug 23 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.40 | 8,600 | 270,054 | 291,400 | 300 K to 291.4 K (-2.87 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.48 | 2,450 | 77,126 | 300,000 | 302.5 K to 300 K (-0.81 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.48 | 2,450 | 77,126 | 300,000 | 302.5 K to 300 K (-0.81 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.55 | 6,950 | 219,242 | 302,450 | 309.4 K to 302.5 K (-2.25 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.55 | 6,950 | 219,242 | 302,450 | 309.4 K to 302.5 K (-2.25 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.07 | 15,600 | 484,680 | 309,400 | 325 K to 309.4 K (-4.80 %) |
Aug 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.07 | 15,600 | 484,680 | 309,400 | 325 K to 309.4 K (-4.80 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.56 | 5,754 | 187,375 | 325,000 | 330.8 K to 325 K (-1.74 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.56 | 5,754 | 187,375 | 325,000 | 330.8 K to 325 K (-1.74 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.35 | 12,295 | 397,773 | 330,754 | 343 K to 330.8 K (-3.58 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.35 | 12,294 | 397,740 | 330,754 | 343 K to 330.8 K (-3.58 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.56 | 6,951 | 226,332 | 343,049 | 350 K to 343 K (-1.99 %) |
Aug 09 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 32.56 | 6,952 | 226,365 | 343,048 | 350 K to 343 K (-1.99 %) |
Aug 02 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 30.85 | 15,700 | 484,384 | 350,000 | 365.7 K to 350 K (-4.29 %) |
Aug 02 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 30.85 | 15,700 | 484,384 | 350,000 | 365.7 K to 350 K (-4.29 %) |
Aug 02 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.62 | 9,300 | 294,090 | 365,700 | 375 K to 365.7 K (-2.48 %) |
Aug 02 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO and Treasurer | Sell | S | 31.62 | 9,300 | 294,090 | 365,700 | 375 K to 365.7 K (-2.48 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 8.98 | 8,000 | 71,840 | 2,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 13.55 | 8,000 | 108,400 | 10,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 9.40 | 8,000 | 75,200 | 18,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 5.14 | 5,000 | 25,700 | 26,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.85 | 5,000 | 19,250 | 31,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.20 | 5,500 | 17,600 | 36,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.20 | 4,500 | 14,400 | 41,500 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.05 | 10,000 | 30,500 | 46,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.20 | 5,000 | 16,000 | 56,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Option Exercise | M | 3.20 | 5,000 | 16,000 | 61,000 | |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Payment of Exercise | F | 33.19 | 11,898 | 394,895 | 66,302 | 78.2 K to 66.3 K (-15.21 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 8.98 | 8,000 | 71,840 | 78,200 | 70.2 K to 78.2 K (+11.40 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 13.55 | 8,000 | 108,400 | 70,200 | 62.2 K to 70.2 K (+12.86 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 9.40 | 8,000 | 75,200 | 62,200 | 54.2 K to 62.2 K (+14.76 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 5.14 | 5,000 | 25,700 | 54,200 | 49.2 K to 54.2 K (+10.16 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.85 | 5,000 | 19,250 | 49,200 | 44.2 K to 49.2 K (+11.31 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.20 | 5,500 | 17,600 | 44,200 | 38.7 K to 44.2 K (+14.21 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.20 | 4,500 | 14,400 | 38,700 | 34.2 K to 38.7 K (+13.16 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.05 | 10,000 | 30,500 | 34,200 | 24.2 K to 34.2 K (+41.32 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.20 | 5,000 | 16,000 | 24,200 | 19.2 K to 24.2 K (+26.04 %) |
Jul 31 2006 | AVM | AMAG PHARMACEUTICA ... | BLOCH SHELDON L | Director | Buy | M | 3.20 | 5,000 | 16,000 | 19,200 | 14.2 K to 19.2 K (+35.21 %) |
Jul 28 2006 | AVM | AMAG PHARMACEUTICA ... | AVALLONE MICHAEL N | VP-Finance and CFO | Option Exercise | A | 33.19 | 4,000 | 132,760 | 4,000 | |
Jul 28 2006 | AVM | AMAG PHARMACEUTICA ... | Farmer Joseph L | Gen Counsel & VP Le ... | Option Exercise | A | 33.19 | 6,250 | 207,438 | 6,250 | |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Buy | J | 0.00 | 20,276 | 0 | 20,276 | 0 to 20.3 K |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.88 | 1,000 | 27,880 | 0 | 1,000 to 0 (-100.00 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.85 | 5,300 | 147,605 | 1,000 | 6.3 K to 1,000 (-84.13 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.83 | 300 | 8,349 | 6,300 | 6.6 K to 6.3 K (-4.55 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.82 | 4,700 | 130,754 | 6,600 | 11.3 K to 6.6 K (-41.59 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.81 | 900 | 25,029 | 11,300 | 12.2 K to 11.3 K (-7.38 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.80 | 6,100 | 169,580 | 12,200 | 18.3 K to 12.2 K (-33.33 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.78 | 200 | 5,556 | 18,300 | 18.5 K to 18.3 K (-1.08 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.75 | 16,100 | 446,775 | 18,500 | 34.6 K to 18.5 K (-46.53 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.74 | 400 | 11,096 | 34,600 | 35 K to 34.6 K (-1.14 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | S | 27.73 | 924 | 25,623 | 25,000 | 25.9 K to 25 K (-3.56 %) |
Jun 19 2006 | AVM | AMAG PHARMACEUTICA ... | ROBERTS EDWARD B | Director | Sell | J | 0.00 | 20,276 | 0 | 35,924 | 56.2 K to 35.9 K (-36.08 %) |
Jun 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Sell | S | 27.70 | 21,331 | 590,839 | 109,589 | 130.9 K to 109.6 K (-16.29 %) |
Jun 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Sell | S | 26.45 | 2,200 | 58,190 | 130,920 | 133.1 K to 130.9 K (-1.65 %) |
Jun 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Sell | S | 26.60 | 200 | 5,320 | 133,120 | 133.3 K to 133.1 K (-0.15 %) |
Jun 16 2006 | AVM | AMAG PHARMACEUTICA ... | GOLDSTEIN JEROME | CEO, President and ... | Sell | S | 26.45 | 1,700 | 44,973 | 133,320 | 135 K to 133.3 K (-1.26 %) |